Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Description

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Conditions

Diabetes Type 2

Study Overview

Study Details

Study overview

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Condition
Diabetes Type 2
Intervention / Treatment

-

Contacts and Locations

San Diego

Scripps Whittier Diabetes Institute, San Diego, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosed with type 2 diabetes
  • * Are not currently using a CGM
  • * Are not using insulin therapies
  • * Speak English, Spanish or Arabic
  • * Have A1c between 7.5% and 12.0% in last 90 days
  • * Have a cellphone that can receive/send text messages and counts steps
  • * Are using insulin therapies
  • * Are pregnant
  • * Are currently using a CGM
  • * Are currently participating in another diabetes-related study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Scripps Whittier Diabetes Institute,

Athena Philis-Tsimikas, MD, PRINCIPAL_INVESTIGATOR, Scripps Health

Study Record Dates

2027-04-30